Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Adam Eckert

Why Tonix Pharmaceuticals Stock Is Soaring

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) shares are trading higher Wednesday after the company announced that the United States Patent and Trademark Office issued a patent to Tonix titled, "Synthetic Chimeric Poxviruses."

The patent includes claims covering synthetic horsepox virus, the basis for the company's TNX-8011 vaccine in development to protect against monkeypox and smallpox and for the company's Recombinant Pox Virus platform to protect against other pathogens, including SARS-CoV-2.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.